. . . . . . . . . . . . . . . . "a(SCHEM:\"Tetradecanoylphorbol acetate\") -> r(HGNC:PTGS2)" . "a(SCHEM:Prolinedithiocarbamate) -| (a(SCHEM:\"Tetradecanoylphorbol acetate\") -> r(HGNC:PTGS2))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Treatment with 30 ng/ml TNF-a or 1 mM TPA led to a 3.2- or 5.2-fold increase, respectively, in COX-2 promoter activity, these effects being inhibited by 64% or 54%, respectively, by 100 mM PDTC (Fig. 12A)." . . "Selventa" . . . . "2014-07-03T14:31:36.783+02:00"^^ . . .